Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract
For these reasons, talk with your doctor about using a GLP-1
Am Fam Physician (2000) 62(5):111927
rather, it represents the synthesized active binding fragment of a much larger, naturally occurring 43-amino-acid protein known as Thymosin Beta-4 (T4)
and c) the predictive role of baseline L-carnitine metabolites levels for cognitive improvement
GLP-1 Pharmacology Glucagon-like peptide 1 agonists simulate the action of incretin, which is a hormone produced by the small intestines, that bind to the GLP-1 receptor
